OUR TEAM REVOLUTION SLIDER TEMPLATE HOOK ME UP

Ricardo Fernandes

MD, PhD | Project Lead

Ricardo Fernandes is a Consultant Pediatrician, at the Department of Pediatrics at Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte and Assistant Professor and Researcher, at the Clinical Pharmacology Unit, of the Faculty of Medicine and Instituto de Medicina Molecular, Universidade de Lisboa. (More information on the profile photo)

Inês Zimbarra Cabrita

PhD | Head of Project Operations

Inês holds a PhD in Cardiovascular Sciences at the National Heart and Lung Institute at Imperial College London (2014). Inês is also the Director of CETERA, an Portuguese Academic Consulting Organization. (More information on the profile photo).

Liliana Bento

MSc | Project Management & SPOC

Liliana has a Degree (2004) and a MSc (2013) in Media Studies from the Instituto Superior de Ciências Sociais e Políticas, Universidade de Lisboa. (More information in the photo profile).

Inês Amaral

B.Sc. | Trial Portfolio Specialist

Inês has a Bachelor’s Degree in Biomedical Sciences (2021) from the University of Aveiro. She began her career in clinical research management in 2021 with a Master’s degree in Clinical Research at the Faculty of Medicine of the University of Lisbon. (More information on the profile photo).

Francisca Patuleia Figueiras

PhD | Trial and Network Operations Officer

Francisca has a Ph.D. in Biomedicine at Universitat Pompeu Fabra, Barcelona, Spain. (More information in the profile photo).

Catarina Sousa

PhD | Pharmacovigilance Specialist

Catarina Sousa is an invited assistant at the Faculty of Medicine, University of Lisbon. She completed her PhD in 2022 in Cardiovascular Sciences at the Faculty of Medicine of the University of Lisbon. (More information in the profile photo).

Fátima Casaca

B.Eng | Financial Coordinator

Fátima Casaca graduated at 2006 at Lisbon Institute of Engineering. Recently, she became a Financial Officer of CETERA. (More information in the profile photo).

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777389. The Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA